Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis

Chest

Volumn 152, Issue 3, 2017, Pages 502-509

  Wang, Ping ^a   Jones, Kirk D ^b   Urisman, Anatoly ^b   Elicker, Brett M ^b   Urbania, Thomas ^b   Johannson, Kerri A ^b   Assayag, Deborah ^b   Lee, Joyce ^b   Wolters, Paul J ^b   Collard, Harold R ^b   Koth, Laura L ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hypersensitivity pneumonitis; lung pathology; prognosis

Indexed keywords

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIOLOCENTRIC FIBROSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FIBROTIC INTERSTITIAL PNEUMONIA; GIANT CELL; GRANULOMA; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LONGITUDINAL STUDY; LUNG BIOPSY; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SURVIVAL RATE; USUAL INTERSTITIAL PNEUMONIA; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BIOPSY; CHRONIC DISEASE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALVEOLITIS, EXTRINSIC ALLERGIC; BIOPSY; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 85028994073     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.02.011     Document Type: Article

References (22)

1. Sharma, O.P., Fujimura, N., Hypersensitivity pneumonitis: a noninfectious granulomatosis. Semin Respir Infect 10:2 (1995), 96–106.
2. Selman, M., Buendía-Roldán, I., Immunopathology, diagnosis, and management of hypersensitivity pneumonitis. Semin Respir Crit Care Med 33:5 (2012), 543–554.
3. Grunes, D., Beasley, M.B., Hypersensitivity pneumonitis: a review and update of histologic findings. J Clin Pathol 66:10 (2013), 888–895.
4. Pereira, C.A., Gimenez, A., Kuranishi, L., Storrer, K., Chronic hypersensitivity pneumonitis. J Asthma Allergy 9 (2016), 171–181.
5. Nunes, H., Schubel, K., Piver, D., et al. Nonspecific interstitial pneumonitis: survival is influenced by the underlying cause. Eur Respir J 45:3 (2015), 746–755.
6. Gaxiola, M., Buendía-Roldán, I., Mejía, M., et al. Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med 105:4 (2011), 608–614.
7. Ohtani, Y., Saiki, S., Kitaichi, M., et al. Chronic bird fancier's lung: histopathologic and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 60:8 (2005), 665–671.
8. Sahin, H., Brown, K.K., Curran-Everett, D., et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 244:2 (2007), 591–598.
9. Churg, A., Sin, D.D., Everett, D., Brown, K., Cool, C., Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 33:12 (2009), 1765–1770.
10. Vourlekis, J.S., Schwarz, M.I., Cherniack, R.M., et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med 116:10 (2004), 662–668.
11. Harada, T., Watanabe, K., Nabeshima, K., et al. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia. Respirology 18:2 (2013), 278–283.
12. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:2 pt 1 (2000), 646–664.
13. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:2 (2002), 277–304.
14. Flaherty, K.R., King, T.E. Jr., Raghu, G., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 170:8 (2004), 904–910.
15. Patel, A.M., Ryu, J.H., Reed, C.E., Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 108:5 (2001), 661–670.
16. Eakin, E.G., Resnikoff, P.M., Prewitt, L.M., Ries, A.L., Kaplan, R.M., Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 113:3 (1998), 619–624.
17. Katzenstein, A.L., Fiorelli, R.F., Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18:2 (1994), 136–147.
18. Nagai, S., Kitaichi, M., Itoh, H., Nishimura, K., Izumi, T., Colby, T.V., Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12:5 (1998), 1010–1019.
19. Travis, W.D., Matsui, K., Moss, J., Ferrans, V.J., Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns. Am J Surg Pathol 24:1 (2000), 19–33.
20. Ley, B., Ryerson, C.J., Vittinghott, E., et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156:10 (2012), 684–691.
21. Raghu, G., Collard, H.R., Egan, J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:6 (2011), 788–824.
22. Du Bois, R.M., Fibroblastic foci: time to be counted?. Chest 130:1 (2006), 3–5.